Closing Market Access Gaps With MMIT's Core Solutions

A pharmaceutical company needed real-time access tracking to "target the right regional payer accounts for contracting discussions" and help its field sales team find "pull-through opportunities and drive prescriptions" for ophthalmic therapies. It partnered with MMIT for three capabilities: segmenting payer/PBM market share by geography, augmenting internal dashboards with low-income-subsidy patient data for Medicare/Medicaid eligibility, and identifying high-value providers with "the largest volume of eligible, covered patients for targeted outreach." No specific numerical outcomes are provided on the page itself.

The customer is anonymised in Norstella’s own case study — not withheld by us.

Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.